High-quality, repeatable imaging is the cornerstone of managing diabetic eye disease
SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.
Investigators use gene therapy treatment of Fuchs in animal models
Successful treatment options can offer hope for patients with inherited disease.
EYS gene complexity key to treatment of retinitis pigmentosa
Investigators believe the therapy could prove to be an option for the treatment of other retinopathies.
Link between neurodevelopmental disorders, visual problems studied
Investigators find that youth show altered ocular movements, reduced amplitude of accommodation.
Netarsudil provides IOP lowering in goniotomy treated eyes
The unique MOA may deliver a synergistic effect when prescribed post-surgically.
Fundraising for vision restoration
An experience at the grocery store serves as a reminder of the importance of fundraising for eye research.
Robotically aligned OCT has potential for use in telemedicine
Pilot study tests the technology to obtain remote fundus imaging of patients.
Seven pearls for a more stable chamber
Staying current on phaco technology can help surgeons provide better outcomes.
Making the grade: FDA approves first biosimilar product for retinal diseases
The FDA has given its approval to Byooviz (ranibizumab-nuna, SB11, Samsung Bioepis Co Inc and Biogen Inc), a biosimilar referencing Lucentis (ranibizumab, Genentech).
2 Clarke Drive Cranbury, NJ 08512